Literature DB >> 18308040

Pancreatic incidentalomas: clinical and pathologic spectrum.

Matias Bruzoni1, Elizabeth Johnston, Aaron R Sasson.   

Abstract

BACKGROUND: Incidental abnormalities are increasingly being detected. The pathology and clinical outcome of patients with pancreatic incidentalomas have not been well characterized.
METHODS: We reviewed the records of 356 patients with pancreatic abnormalities from August 2001 to June 2007. Clinical and pathologic data were collected for a cohort of patients who had incidental pancreatic lesions detected by imaging modalities.
RESULTS: Fifty-seven pancreatic incidentalomas were identified. Ninety percent of them were detected by computed axial tomography (CT). The most frequent indications for imaging were genitourinary symptoms and cancer surveillance. Sixty percent of the lesions were solid, and 40% were cystic. Surgical resection was performed in 33 patients. Locally advanced disease was found in six patients, and metastatic disease was found in 9 patients. The most frequent diagnoses were ductal adenocarcinoma, neuroendocrine tumors, and serous cystadenoma.
CONCLUSIONS: Patients with pancreatic incidentalomas account for a significant patient subgroup. Incidental pancreatic lesions occur frequently and require prompt surgical evaluation.

Entities:  

Mesh:

Year:  2008        PMID: 18308040     DOI: 10.1016/j.amjsurg.2007.12.027

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

1.  Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors.

Authors:  N Volkan Adsay; Olca Basturk; Burcu Saka; Pelin Bagci; Denizhan Ozdemir; Serdar Balci; Juan M Sarmiento; David A Kooby; Charles Staley; Shishir K Maithel; Rhonda Everett; Jeanette D Cheng; Duangpeng Thirabanjasak; Donald W Weaver
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394

2.  Asymptomatic Pancreatic Cancer: Does Incidental Detection Impact Long-Term Outcomes?

Authors:  Yoshinori Takeda; Akio Saiura; Yu Takahashi; Yosuke Inoue; Takeaki Ishizawa; Yoshihiro Mise; Masaru Matsumura; Hirofumi Ichida; Ryota Matsuki; Masayuki Tanaka; Hiromichi Ito
Journal:  J Gastrointest Surg       Date:  2017-04-10       Impact factor: 3.452

Review 3.  The Surgeon's Role in Treating Chronic Pancreatitis and Incidentally Discovered Pancreatic Lesions.

Authors:  Vikrom K Dhar; Brent T Xia; Syed A Ahmad
Journal:  J Gastrointest Surg       Date:  2017-08-14       Impact factor: 3.452

4.  Giant pancreatic incidentaloma: Report of a case and literature review.

Authors:  Petros Charalampoudis; Dimitrios Dimitroulis; Eleftherios Spartalis; Chrysovalantis Vergadis; Anastasios Stofas; Theodore Karatzas
Journal:  Int J Surg Case Rep       Date:  2012-04-24

Review 5.  AACE/ACE disease state clinical review: pancreatic neuroendocrine incidentalomas.

Authors:  Miguel F Herrera; Göran Åkerström; Peter Angelos; Clive S Grant; Ana O Hoff; Juan Pablo Pantoja; Rocio Pérez-Johnston; Dushyant V Sahani; Richard J Wong; Gregory Randolph
Journal:  Endocr Pract       Date:  2015-05       Impact factor: 3.443

6.  Intraductal papillary mucinous neoplasm and the pancreatic incidentaloma.

Authors:  Tara S Kent; Charles M Vollmer; Mark P Callery
Journal:  World J Gastrointest Surg       Date:  2010-10-27

7.  Small and potentially resectable focal pancreatic lesions noted on CT/MRI scans in nonjaundiced patients: likelihood of neoplasia and utility of EUS.

Authors:  Naveen B Krishna; Pavan Tummala; Christopher D Mehan; Amith V Reddy; Jeremy A Hartman; Banke Agarwal
Journal:  J Gastrointest Surg       Date:  2012-01-19       Impact factor: 3.452

8.  The incidental asymptomatic pancreatic lesion: nuisance or threat?

Authors:  Teviah Sachs; Wande B Pratt; Mark P Callery; Charles M Vollmer
Journal:  J Gastrointest Surg       Date:  2009-01-08       Impact factor: 3.452

Review 9.  Current understanding of the molecular biology of pancreatic neuroendocrine tumors.

Authors:  Jianliang Zhang; Rony Francois; Renuka Iyer; Mukund Seshadri; Maria Zajac-Kaye; Steven N Hochwald
Journal:  J Natl Cancer Inst       Date:  2013-07-09       Impact factor: 13.506

10.  Pancreas cancer survival in the gemcitabine era.

Authors:  Mitchell S Wachtel; K Tom Xu; Yan Zhang; Maurizio Chiriva-Internati; Eldo E Frezza
Journal:  Clin Med Oncol       Date:  2008-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.